Quick-Med Technologies, Inc.
- UEI
- CAGMXNKG7XJ1
- CAGE
- 3EE54
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- quickmedtech.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $100,000 |
Contract awards
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Avantguard | Ithaca, NY | 325199 All Other Basic Organic Chemical Manufacturing |
| Xcmr Inc. | Penn Valley, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Sonata Scientific LLC | Danbury, CT | 333413 Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing |
| Acatechol, Inc. | Pasadena, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Nanoionix, Inc. | Farmington, CT | 325180 Other Basic Inorganic Chemical Manufacturing |
About the company
Quick-Med Technologies, Inc. is a life sciences company focused on developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets. Through federal contract and grant awards, the company provides research, development, and commercialization of antimicrobial technologies.
Quick-Med has provided various goods and services related to infection control and prevention through past prime federal contracts. This includes a $500,000 Phase II SBIR contract from the EPA to support research and development of long-term disinfectant coatings for high-touch surfaces using hydrogen peroxide as the active agent. Additionally, Quick-Med was awarded a $99,968 Phase I SBIR contract from the EPA to develop stay-fresh long-term disinfectant coatings for high-touch surfaces based on hydrogen peroxide. The company also received a $49,982 Phase I SBIR contract from the Department of the Air Force for innovative defense-related dual-purpose technologies and solutions. These contracts were all small business set-asides.
Through federal grants, Quick-Med has provided research and development of regenerable antimicrobial paints based on hydrogen peroxide. This includes a $255,999 project grant from the National Science Foundation's Division of Industrial Innovation under the Engineering program to develop regenerable antimicrobial paints using hydrogen peroxide to regenerate antimicrobial properties. This was intended to help address needs around infection control and prevention.
Quick answers
Is Quick-Med Technologies, Inc. registered in SAM.gov?
Quick-Med Technologies, Inc.'s SAM.gov registration expired on March 13, 2026.
How much has Quick-Med Technologies, Inc. received in federal contracts?
Federal contracts obligated $100,000 to Quick-Med Technologies, Inc. in fiscal years 2023 through 2027.
What is Quick-Med Technologies, Inc.'s most recent federal award?
Quick-Med Technologies, Inc.'s most recent federal contract award is FY21-22 EPA sbir phase II - stay-fresh long-term disinfectant coatings for high-touched surfaces based on hydrogen… (68HERC22C0039), from Cincinnati Procurement Operations Division (OAM), on January 1, 2022.
On GovTribe
See Quick-Med Technologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors